Bolwig TG How does electroconvulsive therapy work? Theories on its mechanism. Can J Psychiatry. 2011 Jan;56(1):13-8. Review.
Bolwig TG Neuroimaging and electroconvulsive therapy: a review. J ECT. 2014 Jun;30(2):138-42. doi: 10.1097/YCT.0000000000000140. Review.
Bronge L, Wahlund LO White matter changes in dementia: does radiology matter? Br J Radiol. 2007 Dec;80 Spec No 2:S115-20. doi: 10.1259/bjr/35265137. Review.
Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry. 2014 Jul;15(5):411-8. doi: 10.3109/15622975.2014.892633. Epub 2014 Mar 16. Review.
Campbell JJ 3rd, Coffey CE Neuropsychiatric significance of subcortical hyperintensity. J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):261-88. Review.
Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp. 2008 Jun;29(6):683-95. Erratum in: Hum Brain Mapp. 2008 Jun;29(6):736.
Herrmann LL, Le Masurier M, Ebmeier KP White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):619-24. Epub 2007 Aug 23. Review.
Kranaster L, Janke C, Mindt S, Neumaier M, Sartorius A Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression. J Neural Transm (Vienna). 2014 Nov;121(11):1411-5. doi: 10.1007/s00702-014-1228-9. Epub 2014 May 7.
Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL, Lin WC, Su TP Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage. 2010 Mar;50(1):347-56. doi: 10.1016/j.neuroimage.2009.11.021. Epub 2009 Nov 26.
Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013 Dec 1;10:142. doi: 10.1186/1742-2094-10-142. Review.
Semkovska M, McLoughlin DM Measuring retrograde autobiographical amnesia following electroconvulsive therapy: historical perspective and current issues. J ECT. 2013 Jun;29(2):127-33. doi: 10.1097/YCT.0b013e318279c2c9. Review.
Semkovska M, McLoughlin DM Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010 Sep 15;68(6):568-77. doi: 10.1016/j.biopsych.2010.06.009. Epub 2010 Jul 31. Review.
Shalev H, Serlin Y, Friedman A Breaching the blood-brain barrier as a gate to psychiatric disorder. Cardiovasc Psychiatry Neurol. 2009;2009:278531. doi: 10.1155/2009/278531. Epub 2009 Aug 27.
Sheline YI, Price JL, Yan Z, Mintun MA Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11020-5. doi: 10.1073/pnas.1000446107. Epub 2010 Jun 1.
Taylor SM Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT. 2008 Jun;24(2):160-5. doi: 10.1097/YCT.0b013e3181571ad0. Review.
UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003 Mar 8;361(9360):799-808. Review.
Videbech P, Ravnkilde B Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004 Nov;161(11):1957-66.
Videbech P, Tehrani ES [Imaging techniques and proposed implementation of a neuropsychiatric assessment program for patients with depression]. Ugeskr Laeger. 2007 Apr 16;169(16):1431-4. Danish.
Videbech P MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand. 1997 Sep;96(3):157-68.
Videbech P PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 2000 Jan;101(1):11-20. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.